CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis
2016 · Scientific Reports · 122 citations
https://doi.org/10.1038/srep32804
R
Rui Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
974
Citations
18
h-index
25
i10-index
Rui Shi is an academic researcher from University of Liverpool. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Cancer-related molecular mechanisms research & Endometrial and Cervical Cancer Treatments. The author has an h-index of 18, co-authored 50 publications.
ORCID: 0000-0001-6314-2338Papers by this author
worksHistone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma
2024 · Cell Death Discovery · 88 citations
https://doi.org/10.1038/s41420-024-01898-4
CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer
2022 · Redox Biology · 76 citations
https://doi.org/10.1016/j.redox.2022.102493
GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1
2022 · BMC Cancer · 38 citations
https://doi.org/10.1186/s12885-022-09986-3
RAB17 promotes endometrial cancer progression by inhibiting TFRC-dependent ferroptosis
2024 · Cell Death and Disease · 10 citations
https://doi.org/10.1038/s41419-024-07013-w
Advanced glycation end products promote the progression of endometrial cancer via activating the RAGE/CHKA/PI3K/AKT signaling pathway
2024 · Carcinogenesis · 8 citations
https://doi.org/10.1093/carcin/bgae059
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat